Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hyperhomocysteinemia and other thrombotic risk factors in women with placental vasculopathy.

BJOG : an international journal of obstetrics and gynaecology - 1 Jun 2000

van der Molen E F, Verbruggen B, Nováková I, Eskes T K, Monnens L A, Blom H J

Abstract excerpt

OBJECTIVE: To investigate coagulation inhibitors and abnormalities of the homocysteine metabolism, which are related to an increased thrombotic risk, as risk factors for placental vasculopathy. DESIGN: A case-control study comparing nonpregnant women with an obstetric history of placental vasculopathy (study group) with nonpregnant women (control group) matched for age and occupation. SETTING: Obstetric...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Activated Protein C Resistance
Share to Antithrombin III

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hyperhomocysteinemia

Share to Placenta

Share to Placenta Diseases

Share to Protein C

Share to Protein S

Share to Tetrahydrofolates

Source

Identifiers

PMID: 10847236
DOI: 10.1111/j.1471-0528.2000.tb13341.x

Genes

MTHFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hyperhomocysteinemia and other thrombotic risk factors in women with placental vasculopathy.PMID 10847236Read ↗

A common mutation in the 5,10-methylenetetrahydrofolate reductase gene as a new risk factor for placental vasculopathy.Semantic proximity Read ↗

Thrombophilia and PregnancySemantic proximity Read ↗

Association of MTHFR A1298C polymorphism (but not of MTHFR C677T) with elevated homocysteine levels and placental vasculopathies.Semantic proximity Read ↗

Hypercoagulable thrombophilic defects and hyperhomocysteinemia in patients with recurrent pregnancy loss.Semantic proximity Read ↗

Clotting disorders and placental abruption: homocysteine--a new risk factor.Semantic proximity Read ↗

Vasculopathic and thrombophilic risk factors for spontaneous preterm birth.Semantic proximity Read ↗

Role of polymorphisms in factor V (FV Leiden), prothrombin, plasminogen activator inhibitor type-1 (PAI-1), methylenetetrahydrofolate reductase (MTHFR) and cystathionine β-synthase (CBS) genes as risk factors for thrombophilias.Semantic proximity Read ↗

Placental vascular pathology and increased thrombin generation as mechanisms of disease in obstetrical syndromesSemantic proximity Read ↗

[Prevalence of factor V Leiden, hyperhomocysteinemia, prothrombin G20210A, and methylene tetrahydrofolate reductase C677T mutations in obstetrical complications].Semantic proximity Read ↗

High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia.Semantic proximity Read ↗

Congenital thrombophilia associated to obstetric complications.Semantic proximity Read ↗

Preconception counseling for women with thrombophilia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.